[PDF] Top 20 La economía de la felicidad y los movimientos migratorios
Has 8794 "La economía de la felicidad y los movimientos migratorios" found on our website. Below are the top 20 most common "La economía de la felicidad y los movimientos migratorios".
Central serous chorioretinopathy: a pathogenetic model
... causative model of CSCR allows us to understand how the therapeutic approach cannot be based on a generalized therapy but should be individualized for each patient, and that sometimes a combined strategy of ... See full document
5
Flammer Syndrome, A Potential Risk Factor for Central Serous Chorioretinopathy?
... of CSCR. Choroidal blood-flow changes can be induced through the production of free radicals, inflammatory cells, and nitric oxide. Long-standing choroidal changes and vein congestion together with the extensive ... See full document
69
Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
... Recently, significant progress has been made on the understanding of the pathogenesis of CSCR, regarding the molecular events triggering choroidal vasodilatation in CSCR. Noticeably, CSCR is the only retinal disease ... See full document
7
Low-dose aspirin as treatment for central serous chorioretinopathy
... While the clinical appearance of CSCR is well recognized, less is known about the underlying pathogenetic mechanism of the disease. Dysfunction of the RPE, hyperpermeability of the choroid, and choroidal ischemia ... See full document
5
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
... 0.003). Central foveal thickness decreased in the PDT treatment group from a baseline of 486 microns to 160 microns at 12 months after ...in central foveal thickness from 418 microns to 262 microns at 12 ... See full document
6
Visual Functions after Laser Photocoagulation in Central Serous Chorioretinopathy
... Idiopathic central serous chorioretinopathy (CSC) is a disease first described by Albrecht von Graefe in 1866 as “recurrent central ... See full document
99
Intravitreal Bevacizumab for the Treatment of Chronic or Recurrent Central Serous Chorioretinopathy
... Comparative studies between anti-VEGF therapy and PDT treatment have been performed. Semeraro et al. report the effectiveness and safety of intravitreal bevacizumab injection (IVB) compared with low-fluence pho- ... See full document
6
Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy
... cube. Central macular thickness (CMT) was determined automatically and analyzed by OCT software, by generating images using the macular cube 512 × 128 scan over 6 × 6 mm area, the cube being composed of 128 ... See full document
21
<p>Treatment of central serous chorioretinopathy with topical NSAIDs</p>
... Figure 2 The percentage reduction is calculated as [(Original volume – Follow-up volume)]/(Original Volume)*100%, and incorporated as bar graphs with increments of 10% ranging from “0%” to “100%”. Each bar graph ... See full document
25
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
... determined: central retinal thickness (CRT), central retinal volume (cube volume; CV), average CRT (CRTA), and maximum SRF ...the central circle of the posterior pole measuring 1 mm in diameter, the ... See full document
24
<p>Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment</p>
... with central serous chorioretinopathy, the subfoveal choroid is thicker in eyes with choroidal vascular hyperpermeability than in those ...of central serous ... See full document
8
Novel perspectives on swept-source optical coherence tomography
... Technologies for multimodal digital imaging of vitreoretinal diseases have improved the accuracy of diagnosis and the depth of the knowledge of the mechanisms of disease and their response to treatments. Optic coherence ... See full document
8
In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy
... The key findings of the present study were that, compared to healthy controls, patients suffering from idiopathic CSCR experienced higher anxiety, that anxiety in patients with [r] ... See full document
7
Efficacy of 1/3 Dose Verteporfin Photodynamic Therapy for Subacute Central Serous Chorioretinopathy
... DOI: 10.4236/ojoph.2017.74040 313 Open Journal of Ophthalmology using spectral-domain OCT (Spectralis HRA+OCT, Heidelberg Engineering, Heidelberg, Germany). During post-PDT visits, the locations assessed at baseline were ... See full document
53
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
... Inclusion criteria included: 1. BCVA 20/200 or better, 2. visual symptoms associated with CSCR (such as de- crease vision, central scotoma) lasting for more than 3 months, 3. presence of subretinal fluid involving ... See full document
7
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
... equivalent 20/200); 2) persistent or progressive symptoms, such as visual disturbances or distortions or metamorphop- sia consistent with CSC for more than 3 months; 3) retina pigment epithelium decompensation with focal ... See full document
8
Retinal and choroidal changes in steroid-associated central serous chorioretinopathy
... included central subfield retinal thickness, subfoveal choroidal thickness, subfoveal large choroidal vessel diameter, subretinal deposits, retinal pigment epithelial irregularities, double layer sign, ... See full document
47
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
... Central serous chorioretinopathy (CSC) is a well- characterized self-limiting disorder leading to serous neu- rosensory elevation of the ... See full document
18
Central Serous Chorioretinopathy and Pregnancy: A Case Report
... large serous retinal de- tachment confirming the ...of central ser- ous chorioretinopathy, therapeutic abstention with surveillance has been ... See full document
111
Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
... atrophic retinal abnormalities, and visual acuity at presentation (baseline), and at last available follow-up visit (final follow-up). Information on the use of steroid-containing medication and endogenous ... See full document
20
Related subjects